Skip to main content
Fig. 4 | BMC Nephrology

Fig. 4

From: The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials

Fig. 4

Achievement of primary end points in the EPPIC-USA subgroups. ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, CKD chronic kidney disease, CRP C-reactive protein, eGFR estimated glomerular filtration rate, sCr serum creatinine, UP/UCr Urinary total protein to urinary creatinine ratio

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us